Please select the option that best describes you:
Topics:
Radiation Oncology • Neuro-Oncology
Should we be integrating tumor treating fields into standard glioblastoma treatment?
Are the interim results of EF-14 (Stupp et al) practice changing?
Answer from: Radiation Oncologist at Academic Institution
The EF14 trial preliminary results were just published in JAMA and demonstrate an improvement in both PFS and OS for the experimental arm, and the device has received FDA approval. In the neuro-oncology community, there is still anticipation regarding the final results (the entire cohort outcome da...
Sign in or Register to read more